ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skin care, is proud to announce the launch of…
Read More »Elevai Labs
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, is pleased to announce that the United States…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced certain preliminary, unaudited management-prepared financial results for…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce it has signed an…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announces participation in three aesthetic industry conferences in…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today reported its fiscal 2023 Q3 financial results.…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare is pleased to announce its new partnership with…
Read More »
ELEVAI Labs (NASDAQ: ELAB) a medical aesthetic company specializing in physician-dispensed skincare, announced today the signing of a licensing agreement…
Read More »
Elevai Labs (NASDAQ: ELAB), a medical aesthetic company specializing in physician-dispensed skincare, today announced the closing of its previously announced…
Read More »
Shares of Elevai Labs have been approved for listing on the NASDAQ and Will Commence Trading on November 21, 2023,…
Read More »